DK1581193T3 - Biologisk nedbrydeligt øjenimplantat - Google Patents
Biologisk nedbrydeligt øjenimplantatInfo
- Publication number
- DK1581193T3 DK1581193T3 DK04700611.9T DK04700611T DK1581193T3 DK 1581193 T3 DK1581193 T3 DK 1581193T3 DK 04700611 T DK04700611 T DK 04700611T DK 1581193 T3 DK1581193 T3 DK 1581193T3
- Authority
- DK
- Denmark
- Prior art keywords
- eye implant
- ocular region
- biodegradable
- biodegradable eye
- implants
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/340,237 US20040137059A1 (en) | 2003-01-09 | 2003-01-09 | Biodegradable ocular implant |
PCT/US2004/000351 WO2004062649A2 (en) | 2003-01-09 | 2004-01-07 | Biodegradable ocular implant |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1581193T3 true DK1581193T3 (da) | 2012-06-25 |
Family
ID=32711277
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08002892.1T DK1917957T3 (da) | 2003-01-09 | 2004-01-07 | Bioeroderbart øjenimplantat |
DK14165593.6T DK2799064T3 (da) | 2003-01-09 | 2004-01-07 | Bioeroderbart øjenimplantat |
DK17188114.7T DK3305284T3 (da) | 2003-01-09 | 2004-01-07 | Bionedbrydelig øjeimplantat |
DK16198417.4T DK3187177T3 (da) | 2003-01-09 | 2004-01-07 | Bionedbrydeligt øjenimplantat |
DK04700611.9T DK1581193T3 (da) | 2003-01-09 | 2004-01-07 | Biologisk nedbrydeligt øjenimplantat |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08002892.1T DK1917957T3 (da) | 2003-01-09 | 2004-01-07 | Bioeroderbart øjenimplantat |
DK14165593.6T DK2799064T3 (da) | 2003-01-09 | 2004-01-07 | Bioeroderbart øjenimplantat |
DK17188114.7T DK3305284T3 (da) | 2003-01-09 | 2004-01-07 | Bionedbrydelig øjeimplantat |
DK16198417.4T DK3187177T3 (da) | 2003-01-09 | 2004-01-07 | Bionedbrydeligt øjenimplantat |
Country Status (21)
Country | Link |
---|---|
US (1) | US20040137059A1 (da) |
EP (6) | EP1917957B1 (da) |
JP (1) | JP4223040B2 (da) |
KR (1) | KR20050099008A (da) |
CN (2) | CN100364514C (da) |
AT (1) | ATE555779T1 (da) |
AU (1) | AU2004204744B2 (da) |
BR (2) | BRPI0406692A (da) |
CA (1) | CA2512315C (da) |
CY (4) | CY1118431T1 (da) |
DK (5) | DK1917957T3 (da) |
ES (5) | ES2384875T3 (da) |
FR (1) | FR12C0067I1 (da) |
HK (1) | HK1084021A1 (da) |
HU (4) | HUE036209T2 (da) |
MX (1) | MXPA05007342A (da) |
NZ (1) | NZ540451A (da) |
PT (4) | PT3305284T (da) |
SI (3) | SI3187177T1 (da) |
TR (2) | TR201802793T4 (da) |
WO (1) | WO2004062649A2 (da) |
Families Citing this family (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5869079A (en) * | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
US20060280774A1 (en) * | 1995-06-02 | 2006-12-14 | Allergan, Inc. | Compositions and methods for treating glaucoma |
US6726918B1 (en) | 2000-07-05 | 2004-04-27 | Oculex Pharmaceuticals, Inc. | Methods for treating inflammation-mediated conditions of the eye |
WO2002043785A2 (en) | 2000-11-29 | 2002-06-06 | Oculex Pharmaceuticals, Inc. | Intraocular implants for preventing transplant rejection in the eye |
US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
US20050048099A1 (en) * | 2003-01-09 | 2005-03-03 | Allergan, Inc. | Ocular implant made by a double extrusion process |
US8246974B2 (en) | 2003-05-02 | 2012-08-21 | Surmodics, Inc. | Medical devices and methods for producing the same |
EP1633320A2 (en) | 2003-05-02 | 2006-03-15 | SurModics, Inc. | Implantable controlled release bioactive agent delivery device |
US7125908B2 (en) * | 2003-08-29 | 2006-10-24 | Allergan, Inc. | Treating pain using selective antagonists of persistent sodium current |
US7060723B2 (en) | 2003-08-29 | 2006-06-13 | Allergan, Inc. | Treating neurological disorders using selective antagonists of persistent sodium current |
US20070224278A1 (en) | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
US20050101582A1 (en) | 2003-11-12 | 2005-05-12 | Allergan, Inc. | Compositions and methods for treating a posterior segment of an eye |
WO2005072701A1 (en) | 2004-01-20 | 2005-08-11 | Allergan, Inc. | Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
US8147865B2 (en) | 2004-04-30 | 2012-04-03 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
US20050244466A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Photodynamic therapy in conjunction with intraocular implants |
US8685435B2 (en) | 2004-04-30 | 2014-04-01 | Allergan, Inc. | Extended release biodegradable ocular implants |
US20050244469A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Extended therapeutic effect ocular implant treatments |
US8119154B2 (en) | 2004-04-30 | 2012-02-21 | Allergan, Inc. | Sustained release intraocular implants and related methods |
US7993634B2 (en) | 2004-04-30 | 2011-08-09 | Allergan, Inc. | Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods |
US20050244458A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular neuropathies |
US20050244461A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Controlled release drug delivery systems and methods for treatment of an eye |
US8722097B2 (en) | 2004-04-30 | 2014-05-13 | Allergan, Inc. | Oil-in-water method for making polymeric implants containing a hypotensive lipid |
US8425929B2 (en) * | 2004-04-30 | 2013-04-23 | Allergan, Inc. | Sustained release intraocular implants and methods for preventing retinal dysfunction |
US7799336B2 (en) | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
US8673341B2 (en) | 2004-04-30 | 2014-03-18 | Allergan, Inc. | Intraocular pressure reduction with intracameral bimatoprost implants |
US9498457B2 (en) | 2004-04-30 | 2016-11-22 | Allergan, Inc. | Hypotensive prostamide-containing biodegradable intraocular implants and related implants |
US20050244472A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Intraocular drug delivery systems containing excipients with reduced toxicity and related methods |
KR20070095921A (ko) * | 2004-12-10 | 2007-10-01 | 탈리마 테라퓨틱스 인코포레이티드 | 조갑 단위의 상태를 치료하기 위한 조성물 및 방법 |
US20060275230A1 (en) | 2004-12-10 | 2006-12-07 | Frank Kochinke | Compositions and methods for treating conditions of the nail unit |
AU2011236024B2 (en) * | 2005-03-01 | 2013-05-23 | Allergan, Inc. | Microimplants for ocular administration |
US20060204548A1 (en) * | 2005-03-01 | 2006-09-14 | Allergan, Inc. | Microimplants for ocular administration |
US20090082321A1 (en) * | 2007-09-21 | 2009-03-26 | Allergan, Inc. | Steroid containing drug delivery systems |
US20070178138A1 (en) * | 2006-02-01 | 2007-08-02 | Allergan, Inc. | Biodegradable non-opthalmic implants and related methods |
US20070260203A1 (en) * | 2006-05-04 | 2007-11-08 | Allergan, Inc. | Vasoactive agent intraocular implant |
US8802128B2 (en) * | 2006-06-23 | 2014-08-12 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
EP1917971A1 (en) * | 2006-10-27 | 2008-05-07 | Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) | Substained release formulations comprising very low molecular weight polymers |
US8969415B2 (en) * | 2006-12-01 | 2015-03-03 | Allergan, Inc. | Intraocular drug delivery systems |
US8536190B2 (en) * | 2007-01-30 | 2013-09-17 | Allergan, Inc. | Treating unwanted ocular conditions using an ascomycin macrolactam |
CA2680831A1 (en) * | 2007-03-14 | 2008-09-18 | University Of Washington | Device and method for intraocular drug delivery |
US20080317805A1 (en) * | 2007-06-19 | 2008-12-25 | Mckay William F | Locally administrated low doses of corticosteroids |
KR101571434B1 (ko) * | 2007-09-07 | 2015-11-24 | 마티 테라퓨틱스 인코포레이티드 | 치료 약제의 서방성 약물 코어 |
US8353862B2 (en) | 2007-11-02 | 2013-01-15 | Allergan, Inc. | Drug delivery systems and methods |
US8524267B2 (en) * | 2008-04-18 | 2013-09-03 | Warsaw Orthopedic, Inc. | Dexamethasone formulations in a biodegradable material |
US9125917B2 (en) * | 2008-04-18 | 2015-09-08 | Warsaw Orthopedic, Inc. | Fluocinolone formulations in a biodegradable polymer carrier |
US10064819B2 (en) | 2008-05-12 | 2018-09-04 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
US10588855B2 (en) | 2008-05-12 | 2020-03-17 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
US9095404B2 (en) | 2008-05-12 | 2015-08-04 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
US9877973B2 (en) | 2008-05-12 | 2018-01-30 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
CN102026599A (zh) | 2008-05-12 | 2011-04-20 | 犹他大学研究基金会 | 眼内药物递送装置及相关方法 |
WO2009143288A1 (en) * | 2008-05-20 | 2009-11-26 | Yale University | Biodegradable sustained-release polymeric microparticulates comprising a hydrophobic drug and determined for ophthalmic use |
US20110206773A1 (en) * | 2008-05-20 | 2011-08-25 | Yale University | Sustained delivery of drugs from biodegradable polymeric microparticles |
CN101612111B (zh) * | 2008-06-24 | 2011-11-23 | 上海医药工业研究院 | 醋酸诺美孕酮或其类似物的缓释微球及其制备方法和用途 |
US10842669B2 (en) | 2008-11-13 | 2020-11-24 | Gholam A. Peyman | Ophthalmic drug delivery method |
US10272035B2 (en) | 2008-11-13 | 2019-04-30 | Gholam A. Peyman | Ophthalmic drug delivery method |
US20110125090A1 (en) * | 2008-11-13 | 2011-05-26 | Peyman Gholam A | Ophthalmic drug delivery system and method |
US20100204325A1 (en) * | 2009-02-11 | 2010-08-12 | Allergan, Inc. | Valproic acid drug delivery systems and intraocular therapeutic uses thereof |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
US20100303783A1 (en) * | 2009-05-29 | 2010-12-02 | Allergan, Inc. | Methods of Treating Urogenital-Neurological Disorders Using Tachykinin Retargeted Endopepidases |
US20100303788A1 (en) * | 2009-05-29 | 2010-12-02 | Allergan, Inc. | Methods of Treating Chronic Neurogenic Inflammation Using Galanin Retargeted Endopepidases |
US20100303757A1 (en) | 2009-05-29 | 2010-12-02 | Allergan, Inc. | Methods of Treating Chronic Neurogenic Inflammation Using Interleukin Retargeted Endopepidases |
US20100303794A1 (en) | 2009-05-29 | 2010-12-02 | Allergan, Inc. | Methods of Treating Urogenital-Neurological Disorders Using Glucagon Like Hormone Retargeted Endopepidases |
CA2771289A1 (en) * | 2009-08-14 | 2011-02-17 | Allergan, Inc. | Methods of treating cancer using galanin retargeted endpeptidases |
WO2011020119A2 (en) | 2009-08-14 | 2011-02-17 | Allergan, Inc. | Methods of treating cancer using glucagon-like hormone retargeted endopeptidases |
WO2011020115A2 (en) | 2009-08-14 | 2011-02-17 | Allergan, Inc. | Methods of treating cancer using growth factor retargeted endopeptidases |
US20110070215A1 (en) | 2009-08-14 | 2011-03-24 | Allergan, Inc. | Methods of treating cancer using neurotrophin retargeted endopeptidases |
CN102573875A (zh) | 2009-08-14 | 2012-07-11 | 阿勒根公司 | 使用速激肽再靶向内肽酶治疗癌症的方法 |
KR20120107926A (ko) | 2009-08-14 | 2012-10-04 | 알러간, 인코포레이티드 | 오피오이드 재표적화된 엔드펩티다아제를 사용하여 암을 치료하는 방법 |
CA2789151A1 (en) | 2010-02-08 | 2011-08-11 | Allergan, Inc. | Pyridazine derivatives useful as cannabinoid-2 agonists |
US20130030055A1 (en) | 2010-03-24 | 2013-01-31 | Allergan, Inc. | Compositions and methods for treating hair loss, hair thinning, and hair color loss |
US8349005B2 (en) | 2011-01-03 | 2013-01-08 | Masatoshi Murata | Method for burying implant to choroid |
US20120207704A1 (en) | 2011-02-14 | 2012-08-16 | Allergan, Inc. | Inhibiting Aberrant Blood Vessel Formation Using Growth Factor Retargeted Endopeptidases |
WO2012112432A1 (en) | 2011-02-14 | 2012-08-23 | Allergan, Inc. | Methods of inhibiting aberrant blood vessel formation using opioid retargeted endopeptidases |
WO2012112420A1 (en) | 2011-02-14 | 2012-08-23 | Allergan, Inc. | Treatments using psma ligand endopeptidases |
WO2012112426A1 (en) | 2011-02-14 | 2012-08-23 | Allergan, Inc. | Arginine vasopressin retargeted clostridial endopeptidases for use in treating benign prostatic hyperplasia |
WO2012112434A1 (en) | 2011-02-14 | 2012-08-23 | Allergan, Inc. | Inhibiting aberrant blood vessel formation using retargeted endopeptidases |
US10245178B1 (en) | 2011-06-07 | 2019-04-02 | Glaukos Corporation | Anterior chamber drug-eluting ocular implant |
US9827401B2 (en) | 2012-06-01 | 2017-11-28 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US9308355B2 (en) | 2012-06-01 | 2016-04-12 | Surmodies, Inc. | Apparatus and methods for coating medical devices |
WO2014066644A1 (en) | 2012-10-26 | 2014-05-01 | Allergan, Inc. | Ketorolac-containing sustained release drug delivery systems |
CN112932781A (zh) * | 2013-01-15 | 2021-06-11 | 科罗拉多州立大学董事会, 公司实体 | 泪腺系统给药装置 |
CN105377355A (zh) | 2013-03-14 | 2016-03-02 | 拇趾公司 | 治疗甲单元的感染、疾病或病症的方法 |
CN110302138B (zh) * | 2013-10-31 | 2022-09-30 | 阿勒根公司 | 含前列腺酰胺的眼内植入物及其使用方法 |
AU2015223010A1 (en) * | 2014-02-26 | 2016-09-15 | Allergan, Inc. | Intraocular implant delivery apparatus and methods of use thereof |
JP6655610B2 (ja) | 2014-05-29 | 2020-02-26 | グローコス コーポレーション | 制御された薬物送達機能を備えるインプラント及びそれを使用する方法 |
RU2687176C2 (ru) | 2014-09-11 | 2019-05-07 | Айпоинт Фармасьютикалз Юэс, Инк. | Инъекционное устройство |
FR3028410A1 (fr) | 2014-11-18 | 2016-05-20 | Pierre Coulon | Implant capsulaire multifonctionnel |
US11925578B2 (en) | 2015-09-02 | 2024-03-12 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
WO2017053885A1 (en) | 2015-09-25 | 2017-03-30 | Glaukos Corporation | Punctal implants with controlled drug delivery features and methods of using same |
USD851755S1 (en) | 2015-10-22 | 2019-06-18 | Eyepoint Pharmaceuticals Us, Inc. | Ocular inserter |
WO2017091404A1 (en) | 2015-11-23 | 2017-06-01 | The Regents Of The University Of Colorado, A Body Corporate | Lacrimal system for drug delivery |
CN115120405A (zh) | 2016-04-20 | 2022-09-30 | 多斯医学公司 | 生物可吸收眼部药物的递送装置 |
EP3458030B1 (en) | 2016-05-20 | 2021-05-12 | The Regents of The University of Colorado, A Body Corporate | Lacrimal drug delivery device |
WO2020112816A1 (en) | 2018-11-29 | 2020-06-04 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US11819590B2 (en) | 2019-05-13 | 2023-11-21 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US20210060316A1 (en) * | 2019-08-30 | 2021-03-04 | Intersect Ent, Inc. | Submucosal bioresorbable drug eluting platform |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4322323A (en) * | 1980-12-01 | 1982-03-30 | Alza Corporation | Erodible device comprising surfactant for modifying the rate of erosion of the device |
EP0052916B1 (en) * | 1980-11-10 | 1985-01-02 | Alza Corporation | Erodible polymer containing erosion rate modifier |
US4883457A (en) * | 1983-08-18 | 1989-11-28 | Drug Delivery Systems Inc. | Disposable and/or replenishable transdermal drug applicators and methods of manufacturing same |
US6217911B1 (en) * | 1995-05-22 | 2001-04-17 | The United States Of America As Represented By The Secretary Of The Army | sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres |
US6309669B1 (en) * | 1984-03-16 | 2001-10-30 | The United States Of America As Represented By The Secretary Of The Army | Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix |
US4863457A (en) | 1986-11-24 | 1989-09-05 | Lee David A | Drug delivery device |
JPS63291419A (ja) * | 1987-05-24 | 1988-11-29 | Tatsumo Kk | 加熱処理装置 |
US4997652A (en) * | 1987-12-22 | 1991-03-05 | Visionex | Biodegradable ocular implants |
US4853224A (en) * | 1987-12-22 | 1989-08-01 | Visionex | Biodegradable ocular implants |
US5164188A (en) | 1989-11-22 | 1992-11-17 | Visionex, Inc. | Biodegradable ocular implants |
KR0185215B1 (ko) * | 1990-11-30 | 1999-05-01 | 요시다 쇼오지 | 서방성 안구삽입용 약제 |
US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
US5707643A (en) * | 1993-02-26 | 1998-01-13 | Santen Pharmaceutical Co., Ltd. | Biodegradable scleral plug |
DE69425411T2 (de) | 1993-02-26 | 2001-02-08 | Santen Pharmaceutical Co., Ltd | Biologisch abbaubarer sklerastopfen |
US5443505A (en) | 1993-11-15 | 1995-08-22 | Oculex Pharmaceuticals, Inc. | Biocompatible ocular implants |
US5869079A (en) * | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
US6369116B1 (en) * | 1995-06-02 | 2002-04-09 | Oculex Pharmaceuticals, Inc. | Composition and method for treating glaucoma |
EP0817619A4 (en) * | 1996-01-24 | 1999-02-03 | Us Army | NEW POLY- (LACTIDE / GLUCOLIDE) MICROSPHERES WITH EXTENDED RELEASE "WITHOUT BREAKING" |
KR20010014384A (ko) * | 1997-07-02 | 2001-02-26 | 모리타 다카카즈 | 폴리락트산 공막 플러그 |
US6306426B1 (en) * | 1997-08-11 | 2001-10-23 | Allergan Sales, Inc. | Implant device with a retinoid for improved biocompatibility |
US6217895B1 (en) * | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US6726918B1 (en) * | 2000-07-05 | 2004-04-27 | Oculex Pharmaceuticals, Inc. | Methods for treating inflammation-mediated conditions of the eye |
WO2002043785A2 (en) * | 2000-11-29 | 2002-06-06 | Oculex Pharmaceuticals, Inc. | Intraocular implants for preventing transplant rejection in the eye |
-
2003
- 2003-01-09 US US10/340,237 patent/US20040137059A1/en not_active Abandoned
-
2004
- 2004-01-07 WO PCT/US2004/000351 patent/WO2004062649A2/en active Application Filing
- 2004-01-07 ES ES04700611T patent/ES2384875T3/es not_active Expired - Lifetime
- 2004-01-07 ES ES16198417T patent/ES2735132T3/es not_active Expired - Lifetime
- 2004-01-07 EP EP08002892.1A patent/EP1917957B1/en not_active Expired - Lifetime
- 2004-01-07 HU HUE14165593A patent/HUE036209T2/hu unknown
- 2004-01-07 HU HUE16198417 patent/HUE044965T2/hu unknown
- 2004-01-07 TR TR2018/02793T patent/TR201802793T4/tr unknown
- 2004-01-07 PT PT17188114T patent/PT3305284T/pt unknown
- 2004-01-07 CA CA002512315A patent/CA2512315C/en not_active Expired - Lifetime
- 2004-01-07 DK DK08002892.1T patent/DK1917957T3/da active
- 2004-01-07 ES ES17188114T patent/ES2742152T3/es not_active Expired - Lifetime
- 2004-01-07 BR BR0406692-8A patent/BRPI0406692A/pt not_active Application Discontinuation
- 2004-01-07 EP EP19174341.8A patent/EP3563839A1/en not_active Withdrawn
- 2004-01-07 SI SI200432470T patent/SI3187177T1/sl unknown
- 2004-01-07 KR KR1020057012697A patent/KR20050099008A/ko not_active Application Discontinuation
- 2004-01-07 PT PT141655936T patent/PT2799064T/pt unknown
- 2004-01-07 BR BR122015016901A patent/BR122015016901B8/pt not_active IP Right Cessation
- 2004-01-07 SI SI200432476T patent/SI3305284T1/sl unknown
- 2004-01-07 EP EP04700611A patent/EP1581193B1/en not_active Expired - Lifetime
- 2004-01-07 ES ES14165593.6T patent/ES2661383T3/es not_active Expired - Lifetime
- 2004-01-07 CN CNB2004800020739A patent/CN100364514C/zh not_active Expired - Lifetime
- 2004-01-07 PT PT16198417T patent/PT3187177T/pt unknown
- 2004-01-07 PT PT80028921T patent/PT1917957T/pt unknown
- 2004-01-07 DK DK14165593.6T patent/DK2799064T3/da active
- 2004-01-07 CN CNA2007101990278A patent/CN101259280A/zh active Pending
- 2004-01-07 EP EP17188114.7A patent/EP3305284B1/en not_active Expired - Lifetime
- 2004-01-07 HU HUE17188114 patent/HUE044694T2/hu unknown
- 2004-01-07 HU HUE08002892A patent/HUE030319T2/en unknown
- 2004-01-07 SI SI200432427T patent/SI2799064T1/en unknown
- 2004-01-07 EP EP16198417.4A patent/EP3187177B1/en not_active Expired - Lifetime
- 2004-01-07 DK DK17188114.7T patent/DK3305284T3/da active
- 2004-01-07 DK DK16198417.4T patent/DK3187177T3/da active
- 2004-01-07 TR TR2019/08857T patent/TR201908857T4/tr unknown
- 2004-01-07 DK DK04700611.9T patent/DK1581193T3/da active
- 2004-01-07 AU AU2004204744A patent/AU2004204744B2/en not_active Expired
- 2004-01-07 JP JP2005507695A patent/JP4223040B2/ja not_active Expired - Lifetime
- 2004-01-07 ES ES08002892.1T patent/ES2613028T3/es not_active Expired - Lifetime
- 2004-01-07 NZ NZ540451A patent/NZ540451A/en not_active IP Right Cessation
- 2004-01-07 EP EP14165593.6A patent/EP2799064B1/en not_active Expired - Lifetime
- 2004-01-07 AT AT04700611T patent/ATE555779T1/de active
- 2004-01-07 MX MXPA05007342A patent/MXPA05007342A/es active IP Right Grant
-
2006
- 2006-04-04 HK HK06104158.4A patent/HK1084021A1/xx not_active IP Right Cessation
-
2012
- 2012-11-02 FR FR12C0067C patent/FR12C0067I1/fr active Active
-
2017
- 2017-01-17 CY CY20171100057T patent/CY1118431T1/el unknown
-
2018
- 2018-02-28 CY CY20181100250T patent/CY1120147T1/el unknown
-
2019
- 2019-06-13 CY CY20191100615T patent/CY1121731T1/el unknown
- 2019-08-13 CY CY20191100865T patent/CY1121912T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121731T1 (el) | Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα | |
TW200621263A (en) | Ocular implant made by a double extrusion process | |
WO2002043785A3 (en) | Intraocular implants for preventing transplant rejection in the eye | |
WO2006002366A3 (en) | Biodegradable ocular devices, methods and systems | |
WO2006014484A3 (en) | Methods and devices for the treatment of ocular conditions | |
WO2005110436A3 (en) | Macromolecule-containing sustained release intraocular implants and related methods | |
ATE404140T1 (de) | Vorrichtung zur intraokularen wirkstoffverabreichung | |
WO2004087006A3 (en) | Implant delivery technologies | |
JP2014128739A5 (da) | ||
WO2010059214A3 (en) | Biocompatible biodegradable intraocular implant system | |
WO2005034852A3 (en) | Protein biomaterials and biocoacervates and methods of making and using thereof | |
MX2009005405A (es) | Sistemas intraoculares de distribucion de farmaco. | |
BRPI0712194A2 (pt) | Implantes pélvico e cirúrgico combinação ferramenta cirúrgica útil para implantar um implante pélvico métodos de tratamento de uma condição pélvica, e de prolapso vaginal, e, método para manipular um implante cirúrgico | |
WO2007076508A3 (en) | Implantable graft material | |
TW200603838A (en) | Extended release biodegradable ocular implants | |
WO2004069335A3 (en) | Magnetic implants to treat body tissue structures | |
MX2011008875A (es) | Implantes lagrimales y metodos relacionados. | |
WO2007130134A3 (en) | Controlled release microparticles | |
EP1621219A3 (en) | Intraocular implants for preventing transplant rejection in the eye | |
CA2567140A1 (en) | Methods and apparatus for delivery of ocular implants | |
UA40313A (uk) | Спосіб видалення підвивихнутого кришталика з наступною імплантацією штучного кришталика |